Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
L04AD02 - TacrolimusATC-DDD Version 2016. Source: WHO
L - Antineoplastic and Immunomodulating Agents

This group comprises preparations used in the treatment of malignant neoplastic diseases, and immunomodulating agents.
Corticosteroids for systemic use, see H02.

L04 - Immunosuppressants

Immunosuppressants are defined as agents that completely or partly suppress one or more factors in the immunosystem.

L04A - Immunosuppressants

This group comprises immunosuppressants excl. corticosteroids.

The DDDs are based on prophylaxis of allograft transplant rejection if this is an approved indication.

L04AD - Calcineurin Inhibitors
L04AD02 - Tacrolimus
DoseRoute of administrationNote
5 mgP 
5 mgO 
2019 ¬©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home